Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EDOXABAN TOSILATE for Cerebral infarction: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 8 adverse event reports in the FDA FAERS database where EDOXABAN TOSILATE was used for Cerebral infarction.

Most Reported Side Effects for EDOXABAN TOSILATE

Side Effect Reports % Deaths Hosp.
Cerebral infarction 44 11.8% 9 37
Anaemia 15 4.0% 0 12
Embolic stroke 14 3.7% 0 12
Off label use 14 3.7% 3 6
Cerebrovascular accident 12 3.2% 0 11
Epistaxis 11 2.9% 4 5
Pulmonary embolism 11 2.9% 3 7
Gastrointestinal haemorrhage 10 2.7% 5 7
Cerebral haemorrhage 9 2.4% 5 6
Death 9 2.4% 9 2
Haemorrhage 9 2.4% 0 4
Haemoglobin decreased 8 2.1% 0 7
Interstitial lung disease 8 2.1% 3 7
Platelet count decreased 8 2.1% 1 5
Fall 7 1.9% 2 4

Other Indications for EDOXABAN TOSILATE

Atrial fibrillation (191) Product used for unknown indication (64) Deep vein thrombosis (44) Embolism venous (21) Pulmonary embolism (20) Joint arthroplasty (5) Thrombosis prophylaxis (5)

Other Drugs Used for Cerebral infarction

ALTEPLASE (1,334) CLOPIDOGREL BISULFATE (516) ASPIRIN (461) ATORVASTATIN (235) CILOSTAZOL (154) EDARAVONE (94) RIVAROXABAN (88) ROSUVASTATIN (86) PROBUCOL (58) EDOXABAN (54)

Related Pages

EDOXABAN TOSILATE Full Profile All Cerebral infarction Drugs EDOXABAN TOSILATE Demographics EDOXABAN TOSILATE Timeline